Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CILTACABTAGENE AUTOLEUCEL for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where CILTACABTAGENE AUTOLEUCEL was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for CILTACABTAGENE AUTOLEUCEL

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 570 15.0% 115 340
Pyrexia 242 6.4% 15 147
Immune effector cell-associated neurotoxicity syndrome 232 6.1% 78 126
Parkinsonism 209 5.5% 39 59
Hospitalisation 193 5.1% 0 191
Adverse event 143 3.8% 6 49
Neurotoxicity 140 3.7% 41 76
Death 130 3.4% 130 15
Malaise 126 3.3% 5 18
Fatigue 123 3.2% 6 21
Cranial nerve paralysis 115 3.0% 9 21
Facial paralysis 96 2.5% 9 46
Bell's palsy 95 2.5% 8 44
Haemophagocytic lymphohistiocytosis 91 2.4% 35 40
Pneumonia 87 2.3% 24 56

Other Indications for CILTACABTAGENE AUTOLEUCEL

Product used for unknown indication (2,451) Plasma cell myeloma (1,043) Plasma cell myeloma refractory (132) Plasma cell disorder (27) Neoplasm malignant (6) B-cell lymphoma (5)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

CILTACABTAGENE AUTOLEUCEL Full Profile All Diffuse large b-cell lymphoma Drugs CILTACABTAGENE AUTOLEUCEL Demographics CILTACABTAGENE AUTOLEUCEL Timeline